Skip to main content
Premium Trial:

Request an Annual Quote

Cenix Joins EU siRNA Consortium

Premium

Cenix Bioscience said last week that it has joined a European Union-funded consortium focused on improving the in vivo use of siRNAs for respiratory and inflammatory diseases.

According to the company, it joined the consortium after one-time member Novosom dropped out following the sale of its liposome-based delivery technology to Marina Biotech last year (GSN 7/29/2010).

Cenix said that its specific contributions to the consortium will include its so-called DARE delivery technology, which it began developing in early 2008 as part of an initiative to expand beyond its core focus of high-throughput, high-content RNAi experiments in culture (GSN 4/30/2009).

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.